Literature DB >> 35685049

Is Poliomyelitis Sequelae A Disadvantage for Recovery from Covid-19 ARDS: A Case Report.

Mahir Topaloğlu1, Zeynep Turan1, Suda Tekin2, Evren Şentürk3, Özden Özyemişçi Taşkiran1.   

Abstract

We present a case with acute respiratory distress syndrome due to COVID-19 who had poliomyelitis sequelae. He was hospitalized in the intensive care unit and supported by non-invasive mechanical ventilation for 7 days. IL-6 inhibitor was administered due to cytokine storm. No steroid or sedative agents were administered. Early mobilization was performed in the intensive care unit. One month after discharge, physical examination revealed COVID-19 infection did not cause significant changes in muscle strength and physical performance in this patient with poliomyelitis sequelae. It is important to promote early mobilization in the intensive care unit to prevent post-intensive care syndrome in COVID-19 acute respiratory distress syndrome. Copyright:
© 2022 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  COVID-19; acute respiratory distress syndrome; intensive care unit; muscular weakness; poliomyelitis

Year:  2022        PMID: 35685049      PMCID: PMC9142013          DOI: 10.29399/npa.27438

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.066


  12 in total

1.  EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force.

Authors:  E Farbu; N E Gilhus; M P Barnes; K Borg; M de Visser; A Driessen; R Howard; F Nollet; J Opara; E Stalberg
Journal:  Eur J Neurol       Date:  2006-08       Impact factor: 6.089

2.  The relation between walking capacity and clinical correlates in survivors of chronic spinal poliomyelitis.

Authors:  Sif Gylfadottir; Marijke Dallimore; Elizabeth Dean
Journal:  Arch Phys Med Rehabil       Date:  2006-07       Impact factor: 3.966

3.  Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint.

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2020-06-23

Review 4.  Poliomyelitis.

Authors:  D Kidd; A J Williams; R S Howard
Journal:  Postgrad Med J       Date:  1996-11       Impact factor: 2.401

5.  Mean Hand Grip Strength and Cut-off Value for Sarcopenia in Korean Adults Using KNHANES VI.

Authors:  Jun Il Yoo; Hana Choi; Yong Chan Ha
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

6.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gϋlistan Bahat; Jϋrgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-07-01       Impact factor: 10.668

7.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

8.  Timely rehabilitation for critical patients with COVID-19: another issue should not be ignored.

Authors:  Zhen Wang; Zhongjing Wang; Ruixiang Sun; Xiaoye Wang; Shaofei Gu; Xiancui Zhang; Houbao Huang
Journal:  Crit Care       Date:  2020-06-02       Impact factor: 9.097

Review 9.  Post-polio Syndrome: More Than Just a Lower Motor Neuron Disease.

Authors:  Stacey Li Hi Shing; Rangariroyashe H Chipika; Eoin Finegan; Deirdre Murray; Orla Hardiman; Peter Bede
Journal:  Front Neurol       Date:  2019-07-16       Impact factor: 4.003

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.